Kaposi's sarcoma pathogenesis: A link between immunology and tumor biology

Critical Reviews in Oncogenesis

Volumn 9, Issue 2, 1998, Pages 107-124

  Ensoli, Barbara ^a   Sirianni, Maria Caterina ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Angiogenesis; Cytokines; Herpesviruses; HIV 1; Kaposi's sarcoma

Indexed keywords

ANGIOGENIC FACTOR; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; GROWTH FACTOR; PROTEIN BCL 2; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLAMMATION; KAPOSI SARCOMA; PROTO ONCOGENE; T LYMPHOCYTE SUBPOPULATION;

EID: 0032468720     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v9.i2.20     Document Type: Article

References (138)

1. Ackerman, B. A.: Histologic features of Kaposi's sarcoma and simulators of it. In: Kaposi's Sarcoma (D. Cerimele, Ed.) Spectrum Publications, New York, 71-79 (1985).
2. Albini, A., G. Barillari, R. Benelli, R. C. Gallo, and B. Ensoli: Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. U.S.A., 92:4836-4842 (1995).
3. Albrecht, H., H. J. Stellbrink, G. Gross, B. Berg, U. Helmchen, and H. Mensing: Treatment of atypical leishmaniasis with interferon y resulting in progression of Kaposi's sarcoma in an AIDS patient. Clin. Invest., 72:1041-1047 (1994).
4. Ambroziak, J. A., D. J. Blackbourn, B. G. Herndier, R. G. Glogau, J. H. Gullett, A. R. McDonald, E. T. Lennette, and J. A. Levy: Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science, 268:582-583 (1995).
5. Arvanitakis, L., E. Geras-Raaka, A. Varma, M. C. Gershengorn, and E. Cesarman: Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature, 385:347-349 (1997).
6. Arya, S. K., C. Guo, S. F. Josephs, and F. Wong-Staal: Transactivator gene of human T-lymphotropic virus type III (HTLV-III). Science, 229:69-73 (1985).
7. Ballard, H. S.: Disseminated Kaposi's sarcoma without lymphocyte abnormalities. Arch. Intern. Med., 145:547 (1985).
8. Barillari, G., L. Buonaguro, V. Fiorelli, J. Hoffman, F. Michaels, R. C. Gallo, and B. Ensoli: Effects of cytokines from activated immune cells on vascular cell growth and HIV-I gene expression: Implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol., 149:3727-3734 (1992).
9. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli: The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing RGF amino acid sequence. Proc. Natl. Acad. Sci. U.S.A., 90: 7941-7945 (1993).
10. Barillari, G., V. Fiorelli, R. Gendelman, V. Manzari, R. C. Gallo, and B. Ensoli: HIV-1 Tat protein enhances angiogenesis and Kaposi's sarcoma (KS) development triggered by inflammatory cytokines (IC) or bFGF by engaging the αvβ3 integrin. J. Acq. Immunodef. Synd. Hum. Retrov., 14:A33 (1997).
11. Beckstead, J. H., G. S. Wood, and V. Fletcher: Evidence of the origin of Kaposi's sarcoma from lymphatic endothelium. Am. J. Pathol., 119:294-300 (1985).
12. Blasig, C., C. Zietz, B. Haar, F. Neipel, S. Esser, N. H. Brockmeyer, E. Tschachler, S. Colombini, B. Ensoli, and M. Stürzl: Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus-8. J. Virol., 10:7963-7968 (1997).
13. Bohan-Morris, C., R. Gendelman, A. J. Marrogi, M. Lu, J. M. Lockyer, W. Alpenrein-Lea, and B. Ensoli: Immunohistochemical detection of bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Am. J. Pathol., 148:1055-1063 (1996).
14. Boshoff, C., D. Whitby, T. Hatzioannou, C. Fisher, J. van der Walt, J. Hatzakis, R. Weiss, and T. Schulz: Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet, 345:1043-1044 (1995a).
15. Boshoff, C., T. Acholz, M. M. Kennedy, A. K. Graham, C. Fisher, A. Thomas, J. O'D. McGee, R. A. Weiss, and J. O'Leary: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med., 1:1274-1278 (1995b).
16. Brooks, J. J.: Kaposi's sarcoma: a reversible hyperplasia. Lancet, 2:1309-1311 (1986).
17. Browning, P. J., J. M. G. Sechler, M. Kaplan, R. H. Washington, R. Gendelman, R. Yarchoan, B. Ensoli, and R. C. Gallo: Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of HIV-I-infected individuals and normal controls. Blood, 84:2711-2720 (1994).
18. Buonaguro, L., F. M. Buonaguro, G. Giraldo, and B. Ensoli: The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol., 68:2677-2682 (1994).
19. Buonaguro, F. M., M. L. Tornesello, E. Beth-Giraldo, A. Hatzakis, N. Mueller, R. Downing, B. Biryamwaho, S. D. K. Sempala, and G. Giraldo: Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int. J. Cancer, 65:25-28 (1996).
20. Bussolino, F., J. M. Wang, and P. De Filippi: Granulocyte and granulocyte-macrophages colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature, 337:471-473 (1989).
21. Cesarman, E., P. S. Moore, P. H. Rao, G. Inghirami, D. M. Knowles, and Y. Chang: In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associatedherpesvirus-like (KSHV) DNA sequences. Blood, 86:2708-2714 (1995).
22. Cesarman, E., Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med., 332:1186-1191 (1995).
23. Chang, H. K., R. C. Gallo, and B. Ensoli: Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J. Biomed. Sci., 2:189-202 (1995).
24. Chang, H. C., F. Samaniego, B. C. Nair, L. Buonaguro, and B. Ensoli: HIV-1 Tat protein exits from cells via leaderless secretory pathways and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS, 11:1421-1431 (1997).
25. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266:1865-1869 (1994).
26. Clark, S. C. and R. Kamen: The human hematopoietic colony stimulating factors. Science, 236:1229-1236 (1987).
27. Cornali E., C. Zietz, R. Benelli, W. Weninger, L. Masiello, G. Breier, E. Tshachler, A. Albini, and M. Stürzl: Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am. J. Pathol., 149:1851-1869 (1996).
28. Dictor, M., E. Rambech, D. Way, M. Witte, and N. Bendsoe: Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Am. J. Pathol., 148:2009-2016 (1996).
29. Dorfman, R. F. and F. R. C. Path: The histogenesis of Kaposi's sarcoma. Lymphology, 17:76-77 (1984).
30. Dupin, N., M. Grandadam, V. Calvez, I. Gorin, J. T. Aubin, S. Havard, F. Lamy, M. Leibowitch, J. M. Huraux, J. P. Escande, and H. Agut: Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet, 345:761-762 (1995a).
31. Dupin, N., I. Gorin, J. Deleuze, H. Agut, J. M. Huraux, and J. P. Escande: Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N. Engl. J. Med., 333:798 (1995b).
32. Emilie, D., M. Peuchmaur, M. C. Maillot, M. C. Crevon, N. Brousse, J. F. Delfraissy, J. Dormont, and P. Galanaud: Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Invest., 86:148-159 (1990).
33. Ensoli, B., S. Nakamura, S. Z. Salahuddin, P. Biberfeld, L. Larsson, B. Beaver, F. Wong-Staal, and R. C. Gallo: AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science, 243:223-226 (1989).
34. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal: Tat protein of HIV-I stimulates growth of AIDS-Kaposi's sarcoma-derived cells. Nature, 345:84-86 (1990).
35. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol., 67:277-287 (1993).
36. Ensoli, B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H. K. Chang, J. N. Brady, and R. C. Gallo: Synergy between basic fibroblast growth factor and the HIV-1 Tat protein in induction of Kaposi's sarcoma development. Nature, 321: 674-690 (1994a).
37. Ensoli, B., P. Markham, V. Kao, G. Barillari, V. Fiorelli, R. Gendelman, M. Raffeld, G. Zon, and R. C. Gallo: Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis and lesion formation in nude mice by antisense oligonucleotides targeting basic fibroblast growth factor: a novel strategy for the therapy of KS. J. Clin. Invest., 94:1736-1746 (1994b).
38. Ensoli, B. and R. C. Gallo: Growth factors in AIDS-associated Kaposi's sarcoma: cytokines and HIV-I Tat protein. In: AIDS Updates (V. DeVita, Jr., S. Hellman, and S. A. Rosenberg, Eds.) J.B. Lippincott, Philadelphia, 7:1-12 (1994c).
39. Epperson, D. E. and J. S. Pober: Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells. J. Immunol., 153:5402-5412 (1994).
40. Fagiolo, U., A. Cossarizza, E. Scala, E. Fanales-Belasio, C. Ortolani, E. Cozzi, D. Monti, C. Franceschi, and R. Paganelli: Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol., 23: 2375-2378 (1993).
41. Fan, J., H. Z. Bass, and J. L. Fahev: Elevated IFNγ and decreased IL-2 gene expression are associated with HIV-I infection. J. Immunol., 151:5031-5039 (1993).
42. Faris, M., B. Ensoli, N. Stahl, G. Yancopoulos, A. Nguyen, S. Wang, and A. E. Nel: Differential activation of the ERK, Jun Kinase and Janus Kinase-Stat pathway by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells. AIDS, 10:369-378 (1996).
43. Faris, M., B. Ensoli, N. Kodor, and A. E. Nel: Inflammatory cytokines induce the expression of bFGF isoforms required for growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements of the bFGF promoter. AIDS, 12:19-27 (1998).
44. Fiorelli, V., P. Markham, R. Gendelman, and B. Ensoli: Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest., 95:1723-1734 (1995).
45. Fiorelli, V., R. Gendelman, M. C. Sirianni, H. K. Chang, S. Colombini, P. Markham, P. Monini, J. Sonnabend, A. Pintus, R. C. Gallo, and B. Ensoli: γ-Interferon production by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat protein: an immune response to HHV-8 infection? Blood, 91:956-967 (1998).
46. Foreman, K. E., J. Friborg, W. P. Kong, C. Woffendin, P. J. Polverini, B. J. Nickoloff, and G. J. Nabel: Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N. Engl. J. Med., 336:163-171 (1997).
47. Franceschi, S. and M. Geddes: Epidemiology of classic Kaposi's sarcoma, with special reference to Mediterranean population. Tumori, 81:308-314 (1995).
48. Friedman-Kien, A. E.: Disseminated Kaposi's sarcoma in young homosexual men. J. Am. Acad. Dermatol., 5:468-471 (1981).
49. Gaidano, G., K. Cechasa, Y. Chang, P. S. Moore, D. M. Knowles, and R. Dalla Favera: Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia, 10:1237-1240 (1996).
50. Geddes, M., M. Franceschi, D. Balzi, S. Arniani, L. Gafà, and R. Zanetti: Birthplace and classic Kaposi's sarcoma in Italy. J. Natl. Cancer Inst., 87:1015-1017 (1995).
51. Gendelman, R., V. Fiorelli, V. Kao, R. C. Gallo, and B. Ensoli: Spindle cells from both AIDS-associated and classical Kaposi's sarcoma (KS) lesions are of endothelial cell origin and present an activated phenotype. AIDS Res. Human Retrov., 10:S101 (1994).
52. Gill, P. S., C. Loureiro, M. Bernstein-Singer, M. U. Rarick, F. Sattler, and A. M. Levine: Clinical effect of glucocorticoids on Kaposi's sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med., 110:937-940 (1989).
53. Goodman, J. A.: The immune response. In: Basic and Clinical Immunology (D. P. Stites, A. I. Terr, T. G. Parslow, Eds.) Lange Publications, East Norwalk, CT, 40-50 (1994).
54. Gottlieb, G. J. and A. B. Ackerman: Kaposi's sarcoma: an extensively disseminated form in young homosexual men. Hum. Pathol., 13:882-892 (1982).
55. Guarda, L. G., E. G. Silva, N. G. Ordonez, and J. L. Smith: Factor VIII in Kaposi's sarcoma. Am. J. Clin. Pathol., 76:197-200 (1981).
56. Guo, W-X. and T. Antakly: AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am. J. Pathol., 146:727-734 (1995).
57. Haldar, S., N. Jena, and C. M. Croce: Inactivation of bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. U.S.A., 92:4507-4511 (1995).
58. Harrington, W. J., Jr., O. Bagasra, C. E. Sosa, L. E. Bobroski, M. Baum, X. L. Wen, L. Cabral, G. E. Byrne, R. J. Pomerantz, and C. Wood: Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J. Infect. Dis., 174:1101-1105 (1996).
59. Harrington, W., L. Sieczkowski, C. Sosa, S. Chan-a-Sue, J. P. Cai, and C. Wood: Activation of HHV-8 by HIV-1 Tat. Lancet, 349:774 (1997).
60. Havercos, H. W., D. P. Drotman, and M. Morgan: Prevalence of Kaposi's sarcoma among patients with AIDS. N. Engl. J. Med., 312:1518 (1985).
61. Hober, D., A. Haque, P. Wattre, G. Beucaire, Y. Mouton, and A. Capron: Production of tumor necrosis factor a (TNFα)and interleukin 1 (IL-1) in patients with AIDS. Enhanced level of TNFa is related to higher cytotoxic activity. Clin. Exp. Immunol., 78:329-333 (1989).
62. Honda, M., K. Kitamura, Y. Mizutani, M. Oishi, M. Arai, T. Okura, S. Igarahi, K. Yasukawa, T. Hirano, Y. Kishimoto, R. Mitsuyasu, J. C. Chermann, and T. Tokugana: Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL2R in HIV-1-induced disease. J. Immunol., 145:4059-4064 (1990).
63. Huang, Y. Q., J. J. Li, M. H. Kaplan, B. Poiesz, E. Katabira, W. C. Zhang, D. Feiner, and A. E. Friedman-Kien: Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet, 345:759-762 (1995).
64. Hymes, K. B., L. Cheung, J. B. Greene, N. S. Proste, A. Marcus, H. Ballard, D. C. William, and L. J. Laubenstein: Kaposi's sarcoma in homosexual men - a report of eight cases. Lancet, ii:596-600 (1981).
65. Kaaya, E. E., C. Parravicini, C. Ordonez, R. Gendelman, E. Berti, R. C. Gallo, and P. Biberfeld: Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and culture. J. Acq. Immunodef. Synd. Hum. Retrov., 10:295-305 (1995).
66. Karmann, K., C. C. W. Hughes, J. Schechner, W. C. Fanslow, and J. S. Pober: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. U.S.A., 92:4342-1346 (1995).
67. Kestens, L., M. Melbye, B. J. Biggar, W. J. Stevens, P. Piop, A. De Muinck, H. Taelman, M. De-Feyeter, L. Paluku, and P. L. Gigase: Endemic African Kaposi's sarcoma is not associated with immunodeficiency. Int. J. Cancer, 36:49-54 (1985).
68. Krigel, R. L., C. M. Odajnyk, L. J. Laubenstein, J. Ostreicher, J. Wernz, J. Vilcek, P. Rubinstein, and A. E. Friedman-Kien: Therapeutic trial of interferon γ in patients with epidemic Kaposi's sarcoma. J. Biol. Response Mod., 4:358-364 (1985).
69. Lafrenie, R. M., L. M. Wahl., J. S. Epstein, I. K. Hewlett, K. M. Yamada, and S. Dhawan: HIV-1 Tat protein promotes chemotaxis and invasive behavior by monocytes. J. Immunol., 157:974-977 (1996).
70. Lahdevirta, J., C. P. J. Maury, A. M. Teppo, and H. Repo: Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med., 85:289-291 (1988).
71. Lepe-Zuniga, J. L., P. W. A. Mansell, and E. M. Hersh: Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J. Clin. Microbiol., 25:1695-1700 (1987).
72. Liu, Y. J., D. Y. Mason, G. D. Johnston, S. Abbot, C. D. Gregory, D. L. Hardie, J. Gordon, and I. C. MacLennan: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol., 21:1905-1910 (1991).
73. Lunardi-Iskandar, Y., P. Gill, V. Lam, R. A. Zeman, F. Michaels, D. L. Mann, M. S. Reitz, Jr., M. Kaplan, Z. N. Berneman, D. Carter, J. L. Bryant, and R. C. Gallo: A neoplastic cell line (KS Y-1) from Kaposi's sarcoma (KS): evidence that late stage KS can be a true malignancy. J. Natl. Cancer Inst., 87:974-981 (1995).
74. MacPhail, L. A., N. P. Dekker, and J. A. Regezi: Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma. J. Cutaneous Pathol., 23:464-472 (1996).
75. Maggi, E., M. G. Giudizi, R. Biagiotti, F. Annunziato, R. Manetti, M. P. Piccinni, P. Parronchi, S. Sampognaro, L. Giannarini, G. Zuccati, and S. Romagnani: Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med., 180:489-495 (1994).
76. Mantovani, A., F. Bussolino, and M. Introna: Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol. Today, 18:231-240 (1997).
77. Master, S. P., J. F. Taylor, S. K. Kyalwazi, and M. D. Ziegler: Immunologic studies in Kaposi's sarcoma in Uganda. Br. Med. J., 1:600-602 (1970).
78. Maurice, P. D. L., N. P. Smith, and A. J. Pinching: Kaposi's sarcoma with benign course in a homosexual. Lancet, i:571 (1982).
79. McNutt, N. S., V. Fletcher, and M. A. Conant: Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am. J. Pathol., 111:62-77 (1983).
80. Mesri, E. A., E. Cesarman, L. Arvanitakis, S. Rafii, M. A. S. Moore, D. N. Posnett, D. M. Knowles, and A. Asch: Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J. Exp. Med., 183:2385-2390 (1995).
81. Miles, S. A., A. R. Rezai, J. F. Salazar-Gonzalez, M. VanderMeyden, R. H. Stevens, D. M. Logan, R. T. Mitsuyasu, T. Taga, T. Hirano, T. Kishimoto, and O. Martinez-Maza: AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. U.S.A., 87:4068-4072 (1990).
82. Miles, S. A., O. Martinez-Maza, A. Rezai, L. Maypantay, T. Kishimoto, S. Nakamura, S. F. Radka, and P. S. Linsey: Oncostatin M as a potent mitogen for AIDS-KS-derived cells. Science, 255:1432-1434 (1992).
83. Mitsuyasu, R. T., J. M. Taylor, J. Glaspy, and J. L. Fahey: Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapy. Cancer, 57:1657-1661 (1986).
84. Montesano, R., L. Orci, and P. Vassalli: Human endothelial cell cultures: phenotypic modulation by leukocyte interleukins. J. Cell. Physiol., 122:424-434 (1985).
85. Montmayeur, F., S. Krajewski, F. Bejui-Thivolet, D. Schlaifer, G. Dolsol, J. C. Reed, and P. Brousset: In vivo patterns of apoptosis-regulating protein expression in Kaposi's sarcoma. Appl. Immunohistochem., 5: 104-110 (1997).
86. Moore, P. S., L. Kingsley, S. D. Holmberg, T. Spira, P. Gupta, D. R. Hoover, J. P. Parry, L. Conley, H. W. Jaffe, and Y. Chang: Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS, 10:173-180 (1996a).
87. Moore, P. S., S. J. Gao, G. Dominguez, E. Cesarman, O. Lungu, D. M. Knowles, R. Garber, P. E. Pellett, D. J. McGeoch, and Y. Chang: Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J. Virol., 70:549-558 (1996b).
88. Moore, P. S., C. Boshoff, R. A. Weiss, and Y. Chang: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science, 274:1739-1744 (1996c).
89. Murakami-Mori, K., T. Taga, T. Kishimoto, and S. Nakamura: AIDS-associated Kaposi's sarcoma (KS) cell express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. J. Clin. Invest., 96:1319-1327 (1995).
90. Murakami-Mori, K., T. Taga, T. Kishimoto, and S. Nakamura: The soluble form of IL-6 receptor (sIL-6R-alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells, the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth. Int. Immunol., 8:595-602 (1996).
91. Murphy, P. M.: Pirated genes in Kaposi's sarcoma. Nature, 385:296-299 (1997).
92. Nadji, M., A. R. Morales, J. Zigler-Weissman, and N. S. Pehneys: Kaposi's sarcoma: immunohistologic evidence for an endothelial origin. Arch. Pathol. Lab. Med., 105:274-275 (1981).
93. Nair, B. C., A. L. DeVico, S. Nakamura, T. D. Copeland, Y. Chen, A. Patel, T. O'Neil, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan: Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science, 255:1430-1432 (1992).
94. Nicholas, J., V. R. Ruvolo, W. H. Burns, G. Sandford, X. Wan, D. Ciufo, S. Hendrickson, H. G. Guo, G. S. Haywaed, and M. Reitz: Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nature Med., 3:287-292 (1997).
95. Oppenheim, J. J., C. O. C. Zachariae, N. Mukaida, and K. Matsushima: Properties of the novel proinflammatory supergene "Intercrine" cytokine family. Ann. Rev. Immunol., 9:617-631 (1991).
96. Orenstein, J. M., S. Alkan, A. Blauvelt, K-T. Jeang, M. D. Weinstain, D. Ganem D, B. Herndier B: Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS, 11:35-45 (1997).
97. Oxholm A., P. Oxholm, H. Permin, and K. Bendtzen: Epidermal tumor necrosis factor (alpha) and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. Acta Pathol. Microbiol. Scand., 97:533-538 (1989).
98. Pammer, J., A. Plettensberg, W. Weninger, B. Diller, M. Mildner, A. Uthman, W. Issing, M. Stürzl, and E. Tschachler: CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am. J. Pathol., 148:1387-1396 (1996).
99. Parravicini, C., S. J. Olsen, M. Capra, F. Poli, G. Sirchia, S. J. Gao, E. Berti, A. Nocera, E. Rossi, G. Bestetti, M. Pizzuto, M. Galli, M. Moroni, P. S. Moore, and M. Corbellino: Risk of Kaposi's sarcoma-associated herpesvirus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood, 90:2826-2829 (1997).
100. Penn, I.: Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation, 27:8-11 (1979).
101. Rabkin, C. S., S. Janz, A. Lash, A. E. Coleman, E. Musaba, L. Liotta, R. J. Biggar, and Z. Zhuang: Monoclonal origin of multicentric Kaposi's sarcoma lesions. N. Engl. J. Med., 336:988-993 (1997).
102. Real, F. and S. E. Brown: Spontaneous regression of Kaposi's sarcoma in patients with AIDS. N. Engl. J. Med., 313:1659 (1985).
103. Real, F. X., S. E. Brown, and B. Koziner: Steroid-related development of Kaposi's sarcoma in a homosexual man with Burkitt's lymphoma. Am. J. Pathol., 80:119-122 (1986).
104. Regezi, S. A., L. A. MacPhail, T. E. Daniels, Y. G. De Souza, J. S. Greenspan, and D. Greenspan: Human immunodeficiency virus-associated oral Kaposi's sarcoma: a heterogeneous cell population dominated by spindle-shaped endothelial cells. Am. J. Pathol., 43:240-249 (1993).
105. Rettig, M. B., H. J. Ma, M. A. Vescio, M. Pold, G. Schiller, D. Belson, A. Savage, C. Nishikubo, C. Wu, J. Fraser, J. W. Said, and J. R. Berenson: Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science, 276:1851-1854 (1997).
106. Rizzardini G., S. Piconi, S. Ruzzante, M. L. Fusi, M. Lukwiya, S. Declich, M. Tamburini, M. L. Villa, M. Fabiani, F. Milazzo, and M. Clerici: Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS, 19:1535-1542 (1996).
107. Ruszczak, Z., A. Mayer-Da Silva, and C. E. Orfanos: Kaposi's sarcoma in AIDS. Am. J. Dermatol., 9:388-398 (1987a).
108. Ruszczak, Z., A. Mayer-Da Silva, and C. E. Orfanos: Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma. Dermatologica, 175:270-279 (1987b).
109. Rutgers, J. L., R. Wieczorek, F. Bonetti, K. L. Kaplan, D. N. Posnett, A. E. Friedman-Kien, and D. M. Knowles: The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin. Am. J. Pathol., 122: 493-499 (1986).
110. Safai, B., K. G. Johnson, P. L. Myskowski, B. Koziner, S. Y. Yang, S. Cunningham-Rundles, J. H. Godbold, and B. Dupont: The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann. Intern. Med., 103:744-750 (1985).
111. Salahuddin, S. Z., S. Nakamura, P. Biberfeld, M. H. Kaplan, P. D. Markham, L. Larsson, and R. C. Gallo: Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science, 242:430-433 (1988).
112. Samaniego, F., P. Markham, R. C. Gallo, and B. Ensoli: Inflammatory cytokines induce AIDS-Kaposi's sarcoma (KS)-derived spindle cells to produce and release basic fibroblast growth factor and to enhance KS-like lesion formation in nude mice. J. Immunol., 154:3582-3592 (1995).
113. Samaniego, F., P. D. Markham, R. Gendelman, R. C. Gallo, and B. Ensoli: Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J. Immunol., 158:1887-1894 (1997).
114. Samaniego, F., P. D. Markham, R. Gendelman, Y. Watanabe, V. Kao, K. Kowalski, J. A. Sonnabend, A. Pintus, R. C. Gallo, and B. Ensoli: Vascular endothelial growth factor and basic fibroblast growth factor are expressed in Kaposi's sarcoma and synergize to induce angiogenesis, vascular permeability and KS lesion development: induction by inflammatory cytokines. Am. J. Pathol. 152:1433-1443 (1998).
115. Sarid, R., T. Sato, R. A. Bohenzky, J. J. Russo, and T. Chang: Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nature Med., 3:293-298 (1997).
116. Saville, M. W., J. Lietzau, J. M. Pluda, I. Feuerstein, J. Odon, W. H. Wilson, R. W. Humphrey, E. Feigal, S. M. Steinberg, S. Broder, and R. Yarchoan: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet, 346:26-28 (1995).
117. Scala, G., M. R. Ruocco, C. Ambrosino, M. Mallardo, V. Giordano, F. Baldassarre, E. Dragonetti, I. Quinto, and S. Venuta: The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 Tat protein. J. Exp. Med., 179:961-971 (1994).
118. Schulhafer, E. P., M. E. Grossman, G. Fagin, and K. E. Bell: Steroid-induced Kaposi's sarcoma in a patient with pre-AIDS. Am. J. Med., 82:313-317 (1987).
119. Sciacca, F. L., M. Stürzl, F. Bussolino, A. Sironi, H. Bradstetter, C. Zietz, D. Zhou, C. Matteucci, G. Peri, S. Sozzani, R. Benelli, M. Arese, A. Albini, F. Colotta, and A. Mantovani: Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J. Immunol., 153:4816-4825 (1994).
120. Sirianni, M. C., S. Uccini, A. Angeloni, A. Faggioni, F. Cottoni, and B. Ensoli: Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma. Lancet, 349:255 (1997a).
121. Sirianni, M. C., L. Vincenzi, S. Topino, E. Scala, A. Angeloni, R. Gonnella, S. Uccini, and A. Faggioni: Human herpesvirus 8 DNA sequences in CD8+ T cells. J. Infect. Dis., 176:541 (1997b).
122. Sirianni, M. C., L. Vincenzi, V. Fiorelli, S. Topino, E. Scala, S. Uccini, A. Angeloni, A. Faggioni, D. Cerimele, F. Cottoni, F. Aiuti, and B. Ensoli: γ-Interferon production in peripheral blood mononuclear cells (PBMC) and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages. Blood, 91:968-976 (1998).
123. Slavin, G., H. M. Cameron, and H. Singh: Kaposi's sarcoma in mainland Tanzania: a report of 117 cases. Br. J. Cancer, 23:349-357 (1969).
124. Soulier, J., L. Grollet, E. Oksenhendler, P. Cacoub, D. Cazals-Hatem, P. Babinet, M. F. d'Agay, J. P. Clauvel, M. Raphael, L. Degos, and F. Sigaux: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood, 86:1276-1280 (1995).
125. Stromblad, S. and D. A. Cheresh: Cell adhesion and angiogenesis. Cell Biol., 6:462-468 (1996).
126. Stürzl, M., H. Brandstetter, C. Zietz, B. Eisenburg, G. Raivich, D. Gearing, B. Speiser, N. H., Brockmeyer, and P. H. Hofschneider: Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene, 10:2007-2016 (1995).
127. Stürzl, M., C. Blasig, A. Schreier, F. Neipel, C. Hohenadl, E. Cornali, G. Ascherl, S. Esser, N. H. Brockmeyer, M. Ekman, E. E. Kaaya, E. Tschachler, and P. Biberfeld: Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int. J. Cancer, 72:68-71 (1997).
128. Stürzl., M., G. Ascherl, C. Blasig, S. R. Opalenik, B. Ensoli, and P. J. Browning: Expression of the human herpesvirus-8-encoded viral macrophage inflammatory protein-1 gene in Kaposi's sarcoma lesions. AIDS, 12:1105-1106 (1998).
129. Tabata, M., A. Langford, J. Becker, and P. A. Reichart: Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS). Oral Oncol. Eur. J. Cancer, 29B:209-213 (1993).
130. Taylor, J. F., P. G. Smith, D. Bull, and M. C. Pike: Kaposi's sarcoma in Uganda: geographic and ethnic distribution. Br. J. Cancer, 6:483-491 (1972).
131. Trattner, A., E. Hodak, David, and M. Sandbank: The appearance of Kaposi's sarcoma during corticosteroid therapy. Cancer, 72:1779-1783 (1993).
132. Uccini, S., M. C. Sirianni, L. Vincenzi, S. Topino, A. Stoppacciaro, I. Lesnoni La Parola, M. Capuano, C. Masini, D. Cerimele, M. Cella, A. Lanzavecchia, P. Allavena, A. Mantovani, C. D. Baroni, and L. P. Ruco: Kaposi's sarcoma (KS) cells express the macrophage associated antigen mannose receptor and develop in peripheral blood cultures of KS patients. Am. J. Pathol., 150:929-938 (1997).
133. Vyakarnam, A., P. Matear, A. Meager, G. Kelly, B. Stanley, I. Weller, and P. Beverley: Altered production of tumor necrosis factors alpha and beta and interferon gamma by HIV-I infected individuals. Clin. Exp. Immunol., 84:109-115 (1991).
134. Way, D. L., M. H. Witte, M. Fiala, G. Ramirez, R. B. Nagle, M. J. Bernas, M. Dictor, P. Brogs, and C. L. Witte: Endothelial transdifferentiated phenotype and cell cycle kinetics of AIDS-associated Kaposi's sarcoma cells. Lymphology, 26:79-84 (1993).
135. Whitby, D., M. R. Howard, M. Tenant-Flowers, N. S. Brink, A. Copas, C. Boshoff, T. Hatzioannou, F. E. A. Suggett, D. M. Aldam, A. S. Denton, R. F. Miller, I. V. D. Weller, R. A. Weiss, R. S. Tedder, and T. F. Schulz: Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet, 346:799-803 (1995).
136. Yang, J., M. Hagan, and M. K. Offerman: Induction of IL-6 gene expression in Kaposi's sarcoma cells. J. Immunol., 152:943-955 (1994).
137. Zauli, G., B. R. Davis, M. C. Re, G. Visani, G. Furini, and M. La Placa: Tat protein stimulates production of transforming growth factor-β 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood, 80:3036-3043 (1992).
138. Zauli, G., D. Gibellini, A. Caputo, A. Bassini, M. Negrini, M. Monne, M. Mazzoni, and S. Capitani: The human immunodeficiency virus type-1 Tat protein upregulates bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood, 86:3823-3834 (1995).